Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Method measures latanoprost and minoxidil in skin accurately and precisely.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Dutasteride may help shrink prostate cancer tumors.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Dermoscopy has greatly improved the diagnosis of skin lesions and our understanding of their morphology and biology.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

No link found between aromatase gene and female hair loss.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.

The HairLux device safely and effectively promotes hair growth in people with hair loss.

VEGF and its receptor might cause hair loss.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Finasteride increases risk of sleep apnea and insomnia.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Removing hair wrapped around the labia quickly prevents serious tissue damage.

Clinical pharmacists are crucial in improving patient safety by reporting medication errors in hospitals.